Sagebrush Partners with Southern Nevada Health District to Provide Syphilis Treatment
Las Vegas, Nevada--(Newsfile Corp. - January 17, 2024) - As the United States struggles with a congenital syphilis epidemic and a shortage of the treatment medication Bicillin® L-A , Sagebrush Health ("Sagebrush") has announced that it will be assisting patients who tested positive for the sexually transmitted infection and are referred by the Southern Nevada Health District.
- Las Vegas, Nevada--(Newsfile Corp. - January 17, 2024) - As the United States struggles with a congenital syphilis epidemic and a shortage of the treatment medication Bicillin® L-A , Sagebrush Health ("Sagebrush") has announced that it will be assisting patients who tested positive for the sexually transmitted infection and are referred by the Southern Nevada Health District.
- In particular, Nevada ranked 5th for primary and secondary syphilis and ranked 9th for congenital syphilis rates in 2021.
- Concerned by this issue, the leadership at Sagebrush has partnered with the Southern Nevada Health District to provide treatment for patients with syphilis.
- With the goal of lowering congenital syphilis rates, Sagebrush will also be providing screening for people who are at increased risk for syphilis.